Luncheon Meeting to be held in New York on July 16 hosted by Piper Sandler
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDTX:
- Black Diamond presents data from Phase 1 dose escalation trial of BDTX-1535
- Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
- Black Diamond participates in a conference call with Cantor Fitzgerald
- Black Diamond price target lowered to $11 from $12 at H.C. Wainwright